期刊文献+

低氧诱导因子与骨肿瘤研究进展 被引量:1

The progress about HIFs and bone tumor
下载PDF
导出
摘要 当氧含量不能满足细胞需求时,低氧诱导因子(hypoxia-inducible factors,HIFs)在维持细胞内氧稳态及低氧适应性方面起着至关重要的作用。低氧可显著影响生物体正常发育及疾病进展,尤其是实体瘤的生长。目前,HIFs调节骨肿瘤的发展及转移的机制研究是肿瘤生物学领域的研究重点之一。近年来,多项研究已证实HIFs在骨肿瘤发展方面有着复杂的调控机制,但仍有许多方面没有解决。本文重点对HIFs与骨肿瘤之间的研究进展进行综述。 Hypoxia-inducible factors (HIFs) play an important role in maintaining the homeostasis of cells and the adaptability of hypoxia when the oxygen content is unable to meet the needs of cells. Hypoxia significantly affected the normal development of organisms and the progression of disease, especially the growth of solid tumors. At present, the mechanism of HIFs regulating bone tumor development and metastasis is one of the hot research ifelds of tumor biology. In recent years, many studies have conifrmed that HIFs has a complex regulatory mechanism in the development of bone tumor, but there are still many questions. hTis article reviews the research progress about HIFs and bone tumor.
作者 王进 冯和林
出处 《临床与病理杂志》 2016年第7期1024-1027,共4页 Journal of Clinical and Pathological Research
基金 河北省自然基金面上项目(H2015206314) 河北省医学科学研究重点课题计划(20160159)~~
关键词 低氧诱导因子 骨肿瘤 放化疗 hypoxia-inducible factors (HIFs) bone tumor chemoradiation
  • 相关文献

参考文献3

二级参考文献81

  • 1DE MARTINIS M,DI BENEDETTO M C,MENGOLI L P,et al.Senile osteoporosis:is it an immune-mediated disease[J].Inflammation Research,2006,55(10):399-404.
  • 2DEAL C.Potential new drug targets for osteoporosis[J].Nature Clinical Practice Rheumatology,2009,5(3):20-27.
  • 3SIMONET W S,LACEY D L,DUNSTAN C,et al.Osteoprotegerin:A novel secreted protein involved in the regulation of bone density[J].Cell,1997,89(2):309-319.
  • 4GORI F,HOFBAUER L C,DUNSTAN C R,et al.The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated[J].Endocrinology,2000,141(12):4768-4776.
  • 5WADA T,NAKASHIMA T,HIROSHI N,et al.RANKLRANK signaling in osteoclastogenesis and bone disease[J].Trends in Molecular Medicine,2006,12(1):17-25.
  • 6ANN E K,SUNDEEP K,PAUL K.RANKL and OPG regulation of bone remodeling in health and disease[J].Endocrine Reviews,2008,29(2):155-192.
  • 7ANDERSON D M,MARASKOVSKY E,BILLINGSLEY W L,et al.A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function[J].Nature,1997,390(6656):175-179.
  • 8WRIGHT H L,MCCARTHY H S,MIDDLETON J,et al.RANK,RANKL and osteoprotegerin in bone biology and disease[J].Current Reviews in Museuloskeletal Meddicine,2009,2(1):56-64.
  • 9BOYCE B F,XING L P.Biology of RANK,RANKL,and osteoprotegerin[J].Arthritis Research Therapy,2007,9(Suppl 1):S1.
  • 10NAKAMURA M,UDAGAWA N,MATSUURA S,et al.Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption[J].Endocrinology,2003,144(12):5441-5449.

共引文献42

同被引文献18

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部